Sotera Health (SHC) director Karen Flynn granted 14,970 RSUs as board compensation
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Flynn Karen reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Karen Flynn reported receiving an equity award. She was granted 14,970 restricted stock units (RSUs) on May 22, 2026 under the Sotera Health Company 2020 Omnibus Incentive Plan. After this grant, she holds a total of 54,191 equity interests, consisting of 14,970 RSUs and 39,221 shares of common stock. The RSUs vest fully on the earlier of the first anniversary of the grant date or immediately before the company’s next regular annual shareholders meeting, assuming she continues serving as a non-employee director.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Flynn Karen
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value per share ("Common Stock") | 14,970 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $0.01 par value per share ("Common Stock") — 54,191 shares (Direct, null)
Footnotes (1)
- These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. These securities consist of 14,970 RSUs and 39,221 shares of Common Stock.
Key Figures
RSU grant size: 14,970 RSUs
Grant price per share: $0.00 per share
Total holdings after grant: 54,191 equity interests
+2 more
5 metrics
RSU grant size
14,970 RSUs
Granted on May 22, 2026 under 2020 Omnibus Incentive Plan
Grant price per share
$0.00 per share
Compensation award, not a market purchase
Total holdings after grant
54,191 equity interests
Common stock plus RSUs following the transaction
Common shares held
39,221 shares
Common Stock held after the RSU grant
RSUs outstanding
14,970 RSUs
Each represents right to one share of Common Stock
Key Terms
restricted stock units ("RSUs"), 2020 Omnibus Incentive Plan, non-employee director, beneficially owns
4 terms
restricted stock units ("RSUs") financial
"These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2020 Omnibus Incentive Plan financial
"granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan"
non-employee director financial
"subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date"
beneficially owns financial
"These securities consist of 14,970 RSUs and 39,221 shares of Common Stock."
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
FAQ
What did Sotera Health Co (SHC) director Karen Flynn report in this Form 4?
Karen Flynn reported an equity grant from Sotera Health Co. She received 14,970 restricted stock units, each representing one share of common stock, as compensation for her service as a non-employee director under the company’s 2020 Omnibus Incentive Plan.
How many Sotera Health (SHC) RSUs were granted to Karen Flynn and at what price?
Karen Flynn was granted 14,970 restricted stock units by Sotera Health. The grant price is effectively zero per unit, consistent with a compensation award, and each RSU entitles her to receive one share of common stock upon vesting.
When will Karen Flynn’s Sotera Health (SHC) RSUs vest?
The 14,970 RSUs vest in full on the earlier of the first anniversary of the May 22, 2026 grant date or immediately before Sotera Health’s next regular annual shareholders meeting, provided she continues serving as a non-employee director through that date.
What is Karen Flynn’s total Sotera Health (SHC) equity position after this Form 4 transaction?
Following the grant, Karen Flynn beneficially owns 54,191 Sotera Health equity interests. This total consists of 14,970 restricted stock units and 39,221 shares of common stock, all reported as directly held in the Form 4 filing’s ownership table and footnotes.
Is Karen Flynn’s Sotera Health (SHC) Form 4 transaction a market buy or sale?
The Form 4 shows an acquisition coded as a grant, not a market trade. Karen Flynn received 14,970 RSUs as a compensation award, with no purchase price paid and no open-market buying or selling of common shares reported in this filing.
Under which plan were Karen Flynn’s Sotera Health (SHC) RSUs granted?
The RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan. This plan governs equity-based compensation, and the grant is documented as a restricted stock unit award tied to her continued service as a non-employee director of the company.